Join us next Tuesday, June 9 at 2:00 PM ET for a Meet the Mesothelioma Experts (MTME) interview with Dr. Zachary Horne on Facebook Live.…
1717 K Street NW, Suite 900
Washington, DC 20006-5349
(877) 363-6376
HELPLINE
Anna Nowak, MD, PhD, speaks about immunotherapy and combination of immunotherapy and chemotherapy for mesothelioma patients. She also discusses COVID-19’s effects on mesothelioma in treatment in Australia.…
A phase 2 immunotherapy clinical trial combining durvalumab, an immunotherapy drug, with standard treatment of Alimta (pemetrexed)/cisplatin has shown promising overall survival results. The study enrolled 55 patients and…
Buerkley Rose, MSN, RN, discusses how the University of Chicago’s mesothelioma program has adapted during the COVID-19 pandemic: Clinical Trials: Paused. Telemedicine, including psycho-oncology services: Available. Surgery:…
Dr. R. Taylor Ripley discusses his research interests, diet and cancer, as well as seeking care and the mesothelioma program at Baylor College of Medicine during COVID-19: Telemedicine: Available…
In 2016, the Mesothelioma Applied Research Foundation funded a grant to Antonio Giordano, MD, PhD, director and founder of the Sbarro Health Research Organization at Temple University, to investigate how silencing…
Dr. Marjorie G. Zauderer reviews the changes at Memorial Sloan Kettering Cancer Center, located in NYC, during COVID-19: Telemedicine: Available + Dr. Zauderer provides tips for…
Dr. James Stevenson, a thoracic oncologist at Cleveland Clinic, informs our community on how the COVID-19 pandemic is affecting his institution: Consultations: Available via telemedicine.…
Dr. Antoinette Wozniak, a thoracic oncologist at the University of Pittsburgh Medical Center (UPMC), provides an update about her institution: Standard treatment: Available. Clinical trials: Paused…
Dr. Charles Simone, the chief medical officer and a radiation oncologist focusing on mesothelioma at the New York Proton Center, discusses the contribution of proton…
